These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9158413)

  • 1. bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers.
    Wikonkal NM; Berg RJ; van Haselen CW; Horkay I; Remenyik E; Begany A; Hunyadi J; van Vloten WA; de Gruijl FR
    Arch Dermatol; 1997 May; 133(5):599-602. PubMed ID: 9158413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulators of proliferation and apoptosis in carcinoma of the larynx.
    Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
    Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
    Yan L; Chen M; Yu G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
    Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
    Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
    Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
    Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
    Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover.
    Drachenberg CB; Blanchaert R; Ioffe OB; Ord RA; Papadimitriou JC
    Cancer Detect Prev; 1997; 21(6):483-9. PubMed ID: 9398988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the transcription factor p53 in keratinocyte carcinomas.
    Brash DE
    Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Capaccio P; Carboni N; Pagliari AV; Neri A; Ronchett D; Pruner G; Silvotti MG; Pignataro L; Buffa R; Broich G
    Anticancer Res; 1999; 19(2A):1043-51. PubMed ID: 10368653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.